The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors

OBJECTIVE: Recently, immune checkpoint inhibitor (ICI) treatment has shown encouraging performance in improving the prognosis of hepatocellular carcinoma (HCC) patients. The gut microbiome plays a vital role in altering the efficacy of ICIs, which may be impacted by antibiotics. The aim of the meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lilong, Chen, Chen, Chai, Dongqi, Li, Chunlei, Guan, Yongjun, Liu, Li, Kuang, Tianrui, Deng, Wenhong, Wang, Weixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429218/
https://www.ncbi.nlm.nih.gov/pubmed/36059512
http://dx.doi.org/10.3389/fimmu.2022.956533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429218/
https://www.ncbi.nlm.nih.gov/pubmed/36059512
http://dx.doi.org/10.3389/fimmu.2022.956533

Ejemplares similares